Related Experiment Video
Updated: May 21, 2026

12:28
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Targeting apoptosis signaling pathways for anticancer therapy.
1Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Germany.
Frontiers in Oncology
|June 2, 2012
Summary
Understanding cancer cell death mechanisms is key to overcoming treatment resistance. Targeting specific cell death and survival pathways can lead to more effective, individualized cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cancer treatments like chemotherapy, radiotherapy, and immunotherapy rely on inducing cancer cell death.
- Cancer cells can become resistant to these treatments by evading cell death pathways.
- This resistance necessitates a deeper understanding of cancer cell death and survival mechanisms.
Purpose of the Study:
- To investigate the mechanisms regulating cell death and survival in cancer.
- To identify strategies for overcoming treatment resistance in various cancer types.
- To pave the way for developing novel, molecular-targeted cancer therapies.
Main Methods:
- Analysis of cell death pathways in cancer cells.
- Investigation of cancer cell evasion mechanisms.
- Exploration of signaling pathways involved in cancer survival.
Main Results:
- Identified critical regulators of cancer cell death and survival pathways.
- Elucidated mechanisms by which cancer cells resist therapeutic interventions.
- Highlighted the potential for targeting specific molecular pathways to enhance treatment efficacy.
Conclusions:
- A comprehensive understanding of cell death and survival pathways is crucial for overcoming cancer treatment resistance.
- Targeting deregulated signaling pathways offers a promising strategy for developing effective, individualized cancer therapies.
- Future research should focus on patient- and tumor-specific targeting for improved treatment outcomes.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...